Cafepharma Today

April 18 2024 - AI identifies new potential treatments for Parkinson’s Disease
AI identifies new potential treatments for Parkinson’s Disease
FDA fast-tracks AskBio’s heart failure gene therapy
Biopharma M&A more than doubled in the first quarter compared to the year prior
Vertex inches closer to acute pain market with FDA application acceptance
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex epilepsy drug meets key midstage study goal
Yahoo/AP
Thursday, March 10, 2011 - 6:02pm
tags:
epilepsy, Vertex Pharmaceuticals, VX-765
J&J Unit Signs Consent Decree With U.S. FDA Over 3 Plants
Bloomberg
Thursday, March 10, 2011 - 5:55pm
tags:
JNJ, recalls, consent decree, FDA
Will Celgene Earn or Burn?
Motley Fool
Thursday, March 10, 2011 - 5:54pm
tags:
Celgene
AstraZeneca to Pay $68.5 Million to States Over Seroquel
Bloomberg
Thursday, March 10, 2011 - 12:15pm
tags:
AstraZeneca, Seroquel, settlements
Epizyme snags $206M epigenetics deal with Eisai
Fierce Biotech
Thursday, March 10, 2011 - 12:03pm
tags:
Eisai, Epizyme, epigenetics
Actelion On The Defensive: Corporate Governance White Paper
InVivo
Thursday, March 10, 2011 - 12:02pm
tags:
Actelion
Spectrum Pharmaceuticals 4Q profit falls 56 pct
Yahoo/AP
Thursday, March 10, 2011 - 11:08am
tags:
earnings, Spectrum Pharmaceuticals
KV's Makena delivers $1,500 sticker shock to docs
Fierce Pharma
Thursday, March 10, 2011 - 10:58am
tags:
KV Pharmaceutical, Makena, premature birth
Osiris Profits Rise on Lower Costs
Yahoo/Zacks.com
Thursday, March 10, 2011 - 10:36am
tags:
earnings, Osiris, Genzyme
WuXi PharmaTech on the Right Track With 24% Growth in Revenues
Seeking Alpha
Thursday, March 10, 2011 - 10:35am
tags:
WuXi PharmaTech, China
Exelixis plans $165M stock sale
Bizjournals.com
Thursday, March 10, 2011 - 10:23am
tags:
Exelixis, stock offering
The New Lupus Drug: What The Wags Are Saying
Pharmalot
Thursday, March 10, 2011 - 10:21am
tags:
lupus, Human Genome Sciences, Benlysta
Merck KGaA Seeks Fix for ‘Bunker’ Culture to Woo Investors
Bloomberg
Thursday, March 10, 2011 - 10:20am
tags:
Merck KGaA
Why Dividend Investors Should Consider Eli Lilly
Seeking Alpha
Thursday, March 10, 2011 - 10:11am
tags:
Eli Lilly, dividends
In Defense of Johnson & Johnson: Half a Century of Increasing Dividends
Seeking Alpha
Thursday, March 10, 2011 - 7:52am
tags:
JNJ, dividends
Is This the End of Big Pharma?
Motley Fool
Thursday, March 10, 2011 - 7:51am
tags:
Big Pharma, Pfizer, Lipitor, patents
FDA approves Human Genome's lupus drug
Bizjournals.com
Thursday, March 10, 2011 - 7:49am
tags:
Benlysta, FDA, Human Genome Sciences, lupus
Lilly CEO: No need for megadeals, we have Japan
Fierce Pharma
Wednesday, March 9, 2011 - 5:09pm
tags:
Eli Lilly, John Lechleiter, Japan, Pharma CEOs
Pozen reports 4Q profit on AstraZeneca payment
Yahoo/AP
Wednesday, March 9, 2011 - 5:07pm
tags:
earnings, Pozen
Hospira gets FDA approval for generic cancer drug
Yahoo/AP
Wednesday, March 9, 2011 - 5:07pm
tags:
FDA, generics, Hospira, Taxotere, Sanofi

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information